• 1
    Carbotte R, Denberg S, Denburg J. Prevalence of cognitive impairment in systemic lupus erythematosus. J Nerv Ment Dis 1986; 174: 35764.
  • 2
    Hanly J, Fisk J, Sherwood G, Jones E, Jones J, Eastwood B. Cognitive impairment in patients with systemic lupus erythematosus. J Rheumatol 1992; 19: 5627.
  • 3
    Kozora E, Thompson LL, West SG, Kotzin BL. Analysis of cognitive and psychological deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum 1996; 39: 203545.
  • 4
    Sabbadini M, Manfredi F, Bozzolo E, Ferrario L, Rugarli C, Scorza R, et al. Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations. Lupus 1999; 8: 119.
  • 5
    ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599608.
  • 6
    Denburg S, Carbotte R, Denburg J. Psychological aspects of systemic lupus erythematosus: cognitive function, mood, and self-report. J Rheumatol 1997; 24: 9981003.
  • 7
    Monastero R, Bettini P, del Zotto E, Cottini E, Tincani A, Balestrieri G, et al. Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations. J Neurol Sci 2001; 184: 339.
  • 8
    Denburg S, Stewart K, Hart L, Denburg J. How “soft” are soft neurological signs? The relationship of subjective neuropsychiatric complaints to cognitive function in systemic lupus erythematosus. J Rheumatol 2003; 30: 100610.
  • 9
    Kozora E, Hanly JG, Lapteva L, Filley CM. Cognitive dysfunction in systemic lupus erythematosus: past, present, and future [review]. Arthritis Rheum 2008; 58: 328698.
  • 10
    Yaffe K, Barnes D, Nevitt M, Lui L, Covinsky K. A prospective study of physical activity and cognitive decline in elderly women: women who walk. Arch Intern Med 2001; 161: 17038.
  • 11
    Weuve J, Kang J, Manson J, Breteler MM, Ware J, Grodstein F. Physical activity, including walking, and cognitive function in older women. JAMA 2004; 292: 145461.
  • 12
    Middleton L, Manini T, Simonsick E, Harris T, Barnes D, Tylavsky F, et al. Activity energy expenditure and incident cognitive impairment in older adults. Arch Intern Med 2011; 171: 12517.
  • 13
    Cournot M, Marquie JC, Ansiau D, Martinaud C, Fonds H, Ferrieres J, et al. Relation between body mass index and cognitive function in healthy middle-aged men and women. Neurology 2006; 67: 120814.
  • 14
    Gunstad J, Paul RH, Cohen RA, Tate DF, Spitznagel MB, Gordon E. Elevated body mass index is associated with executive dysfunction in otherwise healthy adults. Compr Psychiatry 2007; 48: 5761.
  • 15
    Angevaren M, Aufdemkampe G, Verhaar HJ, Aleman A, Vanhees L. Physical activity and enhanced fitness to improve cognitive function in older people without known cognitive impairment. Cochrane Database Syst Rev 2008; 3: CD005381.
  • 16
    Petri M, Perez-Gutthann S, Spence D, Hochberg M. Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 1992; 93: 5139.
  • 17
    Petri M. Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort. Lupus 2000; 9: 1705.
  • 18
    Bernatsky S, Boivin J, Joseph L, St. Pierre Y, Moore A, Rajan R, et al. Prevalence of factors influencing cancer risk in women with lupus: social habits, reproductive issues, and obesity. J Rheumatol 2002; 29: 22514.
  • 19
    Katz P, Gregorich S, Yazdany J, Trupin L, Julian L, Yelin E, et al. Obesity and its measurement in a community-based sample of women with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2011; 63: 2618.
  • 20
    Kipen Y, Strauss B, Morand E. Body composition in systemic lupus erythematosus. Br J Rheumatol 1998; 37: 5149.
  • 21
    Oeser A, Chung CP, Asanuma Y, Avalos I, Stein CM. Obesity is an independent contributor to functional capacity and inflammation in systemic lupus erythematosus. Arthritis Rheum 2005; 52: 36519.
  • 22
    Mancuso C, Perna M, Sargent A, Salmon J. Perceptions and measurements of physical activity in patients with systemic lupus erythematosus. Lupus 2011; 20: 23142.
  • 23
    Dos Santos FM, Borges MC, Correia MI, Telles RW, Lanna CC. Assessment of nutritional status and physical activity in systemic lupus erythematosus patients. Rev Bras Reumatol 2010; 50: 6318.
  • 24
    Freemer M, King TJ, Criswell L. Association of smoking with dsDNA autoantibody production in systemic lupus erythematosus. Ann Rheum Dis 2006; 65: 5814.
  • 25
    Thorburn CM, Prokunina-Olsson L, Sterba KA, Lum RF, Seldin MF, Alarcon-Riquelme ME, et al. Association of PCDC1 genetic variation with risk and clinical manifestations of systemic lupus erythematosus in a multiethnic cohort. Genes Immun 2007; 8: 27987.
  • 26
    Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997; 40: 1725.
  • 27
    Yelin E, Trupin L, Katz P, Criswell L, Yazdany J, Gillis J, et al. Work dynamics among persons with systemic lupus erythematosus. Arthritis Rheum 2007; 57: 5663.
  • 28
    Kozora E, Ellison MC, West S. Reliability and validity of the proposed American College of Rheumatology neuropsychological battery for systemic lupus erythematosus. Arthritis Rheum 2004; 51: 8108.
  • 29
    Delis D, Kramer J, Kaplan E, Ober B. California Verbal Learning Test manual: second edition, adult version. San Antonio (TX): Psychological Corporation; 2000.
  • 30
    Rey A. L'examen clinique in psychologie. Paris: Presses Universitaires de France; 1964.
  • 31
    Corwin J, Bylsma FW. “ Psychological examination of traumatic encephalopathy” by A. Rey and “The Complex Figure Copy Test” by P.A. Osterreith. Clin Neuropsychol 1993; 7: 321.
  • 32
    Spreen O, Strauss E. A compendium of neuropsychological tests: administration, norms, and commentary. 2nd ed. New York: Oxford University Press; 1998.
  • 33
    Delis DC, Kaplan E, Kramer JH, Ober BA. Delis-Kaplan Executive Function Scale (D-KEFS). San Antonio: The Psychological Corporation; 2001.
  • 34
    Agresti A, Coull B. Approximate is better than “exact” for interval estimation of binomial proportions. Am Stat 1998; 52: 11926.
  • 35
    Craig C, Marshall A, Sjostrom M, Bauman A, Booth M, Ainsworth B, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003; 35: 138195.
  • 36
    Brown W, Trost S, Bauman A, Mummery K, Owen N. Test-retest reliability of four physical activity measures used in population surveys. J Sci Med Sport 2004; 7: 20515.
  • 37
    Hagstromer M, Oja P, Sjostrom M. The International Physical Activity Questionnaire (IPAQ): a study of concurrent and construct validity. Public Health Nutr 2006; 9: 75562.
  • 38
    Kipen Y, Briganti E, Strauss B, Littlejohn G, Morand E. Three year follow-up of body composition changes in pre-menopausal women with systemic lupus erythematosus. Rheumatology (Oxford) 1999; 38: 5965.
  • 39
    Westhovens R, Nijs J, Taelman V, Dequeker J. Body composition in rheumatoid arthritis. Br J Rheumatol 1997; 36: 4448.
  • 40
    Rall LC, Walsmith JM, Snydman L, Reichlin S, Veldhuis JD, Kehayias JJ, et al. Cachexia in rheumatoid arthritis is not explained by decreased growth hormone secretion. Arthritis Rheum 2002; 46: 25747.
  • 41
    Roubenoff R, Walsmith J, Lundgren N, Snydman L, Dolnikowski G, Roberts S. Low physical activity reduces total energy expenditure in women with rheumatoid arthritis: implications for dietary intake recommendations. Am J Clin Nutr 2002; 76: 7749.
  • 42
    Walsmith J, Abad L, Kehayias J, Roubenoff R. Tumor necrosis factor-α production is associated with less body cell mass in women with rheumatoid arthritis. J Rheumatol 2004; 31: 239.
  • 43
    Visser M, Pahor M, Tylavsky F, Kritchevsky S, Cauley J, Newman A, et al. One- and two-year change in body composition as measured by DXA in a population-based cohort of older men and women. J Appl Physiol 2003; 94: 236874.
  • 44
    Visser M, Kritchevsky S, Goodpaster B, Newman A, Nevitt M, Stamm E, et al. Leg muscle mass and composition in relation to lower extremity performance in men and women aged 70 to 79: the Health, Aging, and Body Composition study. J Am Geriatr Soc 2002; 50: 897904.
  • 45
    Visser M, Fuerst T, Lang T, Salamone L, Harris T, for the Health, Aging, and Body Composition Study —Dual-Energy X -ray Absorptiometry and Body Composition Working Group. Validity of fan-beam dual-energy x-ray absorptiometry for measuring fat-free mass and leg muscle mass. J Appl Physiol 1999; 87: 151320.
  • 46
    Gallagher D, Heymsfield SB, Heo M, Jebb SA, Murgatroyd PR, Sakamoto Y. Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr 2000; 72: 694701.
  • 47
    World Health Organization. Obesity: preventing and managing the global epidemic. Geneva: World Health Organization; 2000.
  • 48
    Karlson E, Daltroy L, Rivest C, Ramsey-Goldman R, Wright E, Patrtridge A, et al. Validation of a systemic lupus activity questionnaire (SLAQ) for population studies. Lupus 2003; 12: 2806.
  • 49
    Yazdany J, Yelin EH, Panopalis P, Trupin L, Julian L, Katz PP. Validation of the Systemic Lupus Erythematosus Activity Questionnaire in a large observational cohort. Arthritis Rheum 2008; 59: 13643.
  • 50
    Sheehan D, Janavs J, Baker K, Harnett-Sheehan K, Knapp E, Sheehan M, et al. M.I.N.I. Mini International Neuropsychiatric Interview: English version 5.0.0. J Clin Psychiatry 1998; 59 Suppl: 3457.
  • 51
    Sheehan D, Lecrubier Y, Sheehan K, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59 Suppl: 2233.
  • 52
    D'Agostino R, Vasan R, Pencina M, Wolf P, Cobain M, Massaro J, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008; 117: 74353.
  • 53
    Bixby W, Spalding T, Haufler A, Deeny S, Mahlow P, Zimmerman J, et al. The unique relation of physical activity to executive function in older men and women. Med Sci Sports Exerc 2007; 39: 140816.
  • 54
    Eggermont L, Milberg W, Lipsitz L, Scherder E, Leveille S. Physical activity and executive function in aging: the MOBILIZE Boston Study. J Am Geriatr Soc 2009; 57: 17506.
  • 55
    Kozora E, Laudenslager M, Lemieux A, West S. Inflammatory and hormonal measures predict neuropsychological functioning in systemic lupus erythematosus and rheumatoid arthritis patients. J Int Neuropsychol Soc 2001; 7: 74554.
  • 56
    Weaver J, Huang M, Albert M, Harris T, Rowe J, Seeman T. Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology 2002; 59: 3718.
  • 57
    Yaffe K, Lindquist K, Penninx B, Simonsick W, Pahor M, Kritchevsky S, et al. Inflammatory markers and cogitation in well-functioning African-American and white elders. Neurology 2003; 61: 7680.
  • 58
    Yaffe K, Kanaya A, Lindquist K, Simonsick E, Harris T, Shorr R, et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004; 292: 223742.
  • 59
    Gunstad J, Bausserman L, Paul R, Tate D, Hoth K, Poppas A, et al. C-reactive protein, but not homocysteine, is related to cognitive dysfunction in older adults with cardiovascular disease. J Clin Neurosci 2006; 13: 5406.
  • 60
    Rafnsson S, Deary I, Smith F, Whiteman M, Rumley A, Lowe G, et al. Cognitive decline and markers of inflammation and hemostasis: the Edinburgh Artery Study. J Am Geriatr Soc 2007; 55: 7007.
  • 61
    Gunstad J, Spitznagel MB, Keary TA, Glickman E, Alexander T, Karrer J, et al. Serum leptin levels are associated with cognitive function in older adults. Brain Res 2008; 1230: 2336.
  • 62
    Hoth K, Haley A, Gunstad J, Paul R, Poppas A, Jefferson A, et al. Elevated C-reactive protein is related to cognitive decline in older adults with cardiovascular disease. J Am Geriatr Soc 2008; 56: 1898903.
  • 63
    Holden K, Lindquist K, Tylavsky F, Rosano C, Harris T, Yaffe K, for the Health ABC Study. Serum leptin level and cognition in the elderly: findings from the Health ABC Study. Neurobiol Aging 2009; 30: 14839.
  • 64
    Kamogawa K, Kohara K, Tabara Y, Uetani E, Nagai T, Yamamoto M, et al. Abdominal fat, adipose-derived hormones and mild cognitive impairment: the J-SHIPP study. Dement Geriatr Cogn Disord 2010; 30: 4329.
  • 65
    Coppack S. Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 2001; 60: 34956.
  • 66
    Geffken D, Cushman M, Burke G, Polak J, Sakkinen P, Tracy R. Association between physical activity and markers of inflammation in a healthy elderly population. Am J Epidemiol 2001; 153: 128692.
  • 67
    Abramson J, Vaccarino V. Relationship between physical activity and inflammation among apparently healthy middle-aged and older US adults. Arch Intern Med 2002; 162: 128692.
  • 68
    Ford E. Does exercise reduce inflammation? Physical activity and C-reactive protein among US adults. Epidemiology 2002; 13: 5618.
  • 69
    Reuben D, Judd-Hamilton L, Harris T, Seeman T. The associations between physical activity and inflammation markers in high-functioning older persons: MacArthur studies of successful aging. J Am Geriatr Soc 2003; 51: 112530.
  • 70
    Colbert L, Visser M, Simonsick E, Tracy R, Newman A, Kritchevsky S, et al. Physical activity, exercise, and inflammatory markers in older adults: findings from the Health, Aging, and Body Composition study. J Am Geriatr Soc 2004; 52: 1098104.